Use and overuse of antimigraine drugs by pharmacy personnel in France: COTA survey: Research submission

Headache

Volumn 49, Issue 7, 2009, Pages 1014-1021

  Donnet, Anne ^a   Lantéri Minet, Michel ^b,c   Aucoin, François ^d   Allaf, Bashar ^e  

^a TIMONE HOSPITAL   (France)

^b PASTEUR HOSPITAL   (France)

^c INSERM   (France)

^d Pharmacist   (France)

^e Almirall SAS   (France)

Author keywords

Medication overuse; Migraine; Migraine management; Pharmacy personnel; Self medication

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMIGRAINE AGENT; ERGOTAMINE; IBUPROFEN; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TRIPTAN DERIVATIVE;

ADULT; AGED; ARTICLE; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MISUSE; DRUG USE; FEMALE; FRANCE; HEALTH PERSONNEL ATTITUDE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PHARMACIST ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; SELF CARE; SYMPTOMATOLOGY;

ADULT; ANALGESICS; FEMALE; FRANCE; HEALTH PERSONNEL; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; PHARMACY; PROBABILITY; QUESTIONNAIRES;

EID: 67651229045     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01395.x     Document Type: Article

References (12)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache disorders, 2nd edition. Cephalalgia. 2004 24 (Suppl. 1 9 160.
2. Lantéri-minet M, Valade D, Géraud G, Chautard MH, Lucas C. Migraine and probable migraine. Results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification. Cephalalgia. 2005 25 : 1146 1158.
3. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: Epidemiology and patterns of health care use. Neurology. 2002 58 : 885 894.
4. Lantéri-Minet M, Massiou H, Nachit-Ouinekh F, et al. The GRIM2005 study of migraine consultation in France. I. Determinants of consultation for migraine headache in France. Cephalalgia. 2007 27 : 1386 1397.
5. Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004 3 : 475 483.
6. Lucas C, Auray JP, Gaudin AF, et al. Use and misuse of triptans in France: Data from the GRIM2000 population survey. Cephalalgia. 2004 24 : 197 205. (Pubitemid 38333779)
7. Lucas C, Chaffaut C, Artaz MA, Lantéri-Minet M. FRAMIG 2000: Medical and therapeutic management of migraine in France. Cephalalgia. 2005 25 : 267 279.
8. Haute Autorité de Santé. Professional recommendation. Diagnostic and therapeutic management of migraine in adults and children: Clinical and economical aspects. October 2002; Available at: http://www.has-sante.fr/portail/display.jsp?id=c-272212 [in French G, Lantéri-Minet M, Lucas C. Valade D for the French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther. 2004 26 : 1305 1318.
9. Henry P, Auray JP, Gaudin AF, et al. Prevalence and clinical characteristics of migraine in France. Neurology. 2002 59 : 232 237.
10. Lucas C, Géraud G, Valade D, Chautard MH, Lantéri-Minet M. Recognition and therapeutic management of migraine in 2004, in France: Results of FRAMIG 3, a French nationwide population-based survey. Headache. 2006 46 : 715 725.
11. Lanteri-Minet M, Chautard MH, Lucas C. Chronic migraine and medication overuse: Results of Framig 3, a French population-based survey carried out according to the 2004 IHS classification. Neurology. 2005 64 Suppl. 1 A132.
12. Søndergaard J, Foged A, Kragstrup J, et al. Intensive community pharmacy intervention had little impact on triptan consumption: A randomized controlled trial. Scand J Prim Health Care. 2006 24 : 16 21.